HTG Molecular Diagnostics Inc. (Nasdaq: HTGM) will begin offering its direct target sequencing chemistry in the company's VERI/O laboratory as a service beginning in the first quarter of 2017. The stock price more than doubled by leaping $1.95 to close at $3.18.
HTG Molecular to offer direct target sequencing
February 27, 2017 at 17:17 PM EST
